This inventor holds 9 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: The Broad Institute, Inc., Bayer Pharma Aktiengesellschaft, Dana-Farber-Cancer Institute Inc.. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Cambridge, MA (US) (2021 - 2023)
- Winchester, MA (US) (2021 - 2024)
Company Filing History:
9 out of 488 
7 out of 387 
7 out of 1,268 
Years Active: 2021-2025
Title: The Innovative Contributions of Inventor Xiaoyun Wu
Introduction
Xiaoyun Wu, a prominent inventor based in Cambridge, MA, has made significant contributions to the field of cancer research through his innovative inventions. With a portfolio of six patents, Wu is recognized for his dedication to developing solutions that enhance cancer treatment and patient stratification.
Latest Patents
Among Wu's latest patents is a groundbreaking invention focused on "Compounds, compositions and methods for cancer patient stratification and cancer treatment." This invention outlines improved compounds and methods that utilize biomarkers, such as PDE3A, SLFN12, and CREB3L1, which correlate with drug sensitivity. This advancement allows for the treatment of a tailored patient population using agents derived from his research. Another notable patent by Wu involves "Dihydrooxadiazinones," which outlines compounds that can be synthesized for pharmaceutical use. These compounds are aimed at treating hyperproliferative diseases, providing opportunities for better therapeutic interventions.
Career Highlights
Xiaoyun Wu has amassed a wealth of experience through his work with esteemed organizations. Notably, he has been affiliated with Bayer Pharma Aktiengesellschaft and The Broad Institute, Inc., where he has contributed to various innovative projects aimed at battling cancer. His extensive work in research and development has positioned him as a key figure in biomedical innovation.
Collaborations
Wu's collaborations with leading scientists enhance his research potential. He has worked alongside notable figures such as Matthew Meyerson and Martin Lange, contributing to a collaborative environment that drives innovation in cancer research and treatment. These partnerships are crucial for developing comprehensive strategies to tackle the complexities of cancer.
Conclusion
Xiaoyun Wu's inventions and patents exemplify his commitment to improving cancer treatment and patient care. His innovative approach, combined with collaborations in the field, continues to pave the way for advancements that could significantly impact the future of medical treatments. Wu's work is a testament to the importance of innovation in addressing critical health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile